ArticleAntimicrobial agents and chemotherapy2013

GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.

Pedro Miguel Salcedo Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.